The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
Vanguard CIVThis page contains information on Vanguard CIV for veterinary use.
The information provided typically includes the following:
- Vanguard CIV Indications
- Warnings and cautions for Vanguard CIV
- Direction and dosage information for Vanguard CIV
Vanguard CIVThis treatment applies to the following species:
Canine Influenza Vaccine, H3N8, Killed Virus
For use by, or under the supervision of, a veterinarian.
For vaccination of healthy dogs as an aid in the control of disease associated with canine influenza (H3N8) virus infection. Vanguard CIV has been demonstrated to reduce incidence and severity of lung lesions, and the incidence and duration of clinical coughing and viral shedding.
Directions For Use
Vaccination of healthy dogs is recommended. Shake well. Aseptically administer 1 mL subcutaneously. Healthy dogs 8 weeks of age and older should receive 2 doses administered 3 weeks apart. Annual revaccination with a single dose is recommended.
PrecautionsStore at 2°-7°C (35°-45°F). Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze. Use entire contents when first opened. Sterilized syringes and needles should be used to administer this vaccine. Contains gentamicin as preservative.
Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471 (USA), (800) 461-0917 (Canada).
For veterinary use only
U.S. Veterinary License No. 190
Zoetis Inc., Kalamazoo, MI 49007, USA
10 1-dose (1-mL) vials of vaccine
25 1-dose (1-mL) vials of vaccine
NAC No.: 3690267.6
333 PORTAGE STREET, KALAMAZOO, MI, 49007
|Every effort has been made to ensure the accuracy of the Vanguard CIV information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2018 North American Compendiums. Updated: 2018-04-26